Problem: The traditional pharma model in India is fragmented, inefficient, and suffers from poor reach, spurious drugs, and high inventory costs, leading to inflated drug prices. Solution: E-pharmacies disrupt the market by offering direct services, home delivery, consultations, and cost-effective alternatives. A 'pull' inventory model based on real-time consumption data can reduce lead times, improve efficiency, and cut inventory costs. Benefits: This model enhances product availability, reduces excess stock, and boosts market coverage. Pharma companies can offer competitive prices and improve customer service, even in remote areas. Collaborating with hyperlocal platforms ensures fast delivery, helping pharma stay competitive against e-pharmacies.

Key Takeaways

Traditional pharmaceutical distribution faces poor reach, availability issues, and high inventory costs, making them vulnerable to threats from e-pharmacies. How can they counter this threat?

Rethinking Indian pharma distribution: Countering e-pharmacies

<h4>Rethinking Indian pharma distribution</h4>

Download PDF

Will the direct-to-customer model of e-pharmacies overtake the traditional multi-echelon distribution model of pharmaceutical companies?